U.S. Bankruptcy Judge Kevin Gross ruled in favor of Philadelphia-based Hahnemann, which says the money will help the hospital pay its creditors.
The ruling came despite objection from CMS, which funds the residency programs. Lawyers from CMS argued the sale was against the law and Hahnemann’s Medicare agreement terminates upon closure and can’t be transferred to other institutions.
The federal government has one week to appeal the decision.
The coalition of six health systems — Philadelphia-based Jefferson Health, Einstein Healthcare Network and Temple University Health System, as well as Bryn Mawr, Pa.-based Main Line Health, Camden, N.J.-based Cooper University Health Care and Wilmington, Del.-based Christiana Care Health System — won a bid to buy Hahnemann’s more than 550 residency slots for $55 million in August.
Hahnemann filed for bankruptcy in June and will close Sept. 6.
Read the full report here.
More articles on transactions and valuation:
Health industry transactions ramped up in July
CHS sells 2 Florida hospitals
Quorum’s sale of California hospital moves forward
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
